Shots:Patrick spoke about the 3-month data from the First-in-Human glaucoma treatment trial of Spyglass’ innovative drug delivery platform that helps in lowering intraocular pressure in patients with glaucoma or ocular hypertensionPatrick also talked about the study design and key findings from the First-in-Human glaucoma treatment trialThe interview gives an understanding of Spyglass’…
